TITILOPE FASIPE to Adolescent
This is a "connection" page, showing publications TITILOPE FASIPE has written about Adolescent.
Connection Strength
0.107
-
Eculizumab for management of hyperhemolysis syndrome in pediatric patients with sickle cell disease: A single-center case series. Pediatr Blood Cancer. 2024 Aug; 71(8):e31061.
Score: 0.055
-
Risk factors and co-morbidities in adolescent thromboembolism are different than those in younger children. Thromb Res. 2016 May; 141:178-82.
Score: 0.015
-
Splenic complications in pediatric sickle cell disease: A retrospective cohort review. Pediatr Blood Cancer. 2024 Oct; 71(10):e31219.
Score: 0.014
-
Racial Disparities in Mental Health Disorders in Youth with Chronic Medical Conditions. J Pediatr. 2023 08; 259:113411.
Score: 0.013
-
Novel dose escalation to predict treatment with hydroxyurea (NDEPTH): A randomized controlled trial of a dose-prediction equation to determine maximum tolerated dose of hydroxyurea in pediatric sickle cell disease. Am J Hematol. 2020 09; 95(9):E242-E244.
Score: 0.010